Pneumagen Announces Scientific Advisory Board and Development Team Appointments
Pneumagen Announces £4m fundraising and Commits to Clinical Trial Development for COVID-19
Pneumagen Ltd’s Recent COVID-19 Data Covered by BBC’s “The Nine”
Pneumagen Ltd Announces Positive Anti–Viral Activity for Novel Glycan Approach in Preventing COVID–19 Infections
Pneumagen Ltd Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections
Pneumagen Presents Poster on Multivalent Sialic Acid-binding Proteins as a Novel Preventative and Treatment of RSV at RSVVW 2019
Pneumagen Demonstrates Preclinical Proof-of-Concept in Oncology for Neumonco, a Novel Carbohydrate Binding Module
Pneumagen Demonstrates Preclinical Proof-of-Concept for Neumifil™ in Respiratory Syncytial Virus Infections
Pneumagen Appoints Scientific Advisory Board
Biotech Showcase and J.P. Morgan Healthcare Conference I January 13th – 16th 2025
Jefferies London Healthcare Conference I 19th-21st November 2024
BIO-Europe in Sweden I November 4th-6th 2024
Bio€quity Europe in San Sebastian, Spain | May 12th – 14th 2024
BioTrinity in London | April 23 – 24th 2024
J.P. Morgan Healthcare Conference and Biotech Showcase I January 8th – 11th 2024
Jefferies London Healthcare Conference I November 14th – 16th 2023
BARDA Industry Day in Washington I November 13th-14th 2023
BIO-Europe in Munich I November 6th-8th 2023
Website powered by 100% renewable energy